PainReform Announces Safety Data For PRF-110; Maximum Blood Levels At 10% Of FDA Safety Threshold
Portfolio Pulse from Benzinga Newsdesk
PainReform announced safety data for its PRF-110 product, revealing that maximum blood levels are at 10% of the FDA safety threshold.
August 07, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
PainReform announced that its PRF-110 product has maximum blood levels at only 10% of the FDA safety threshold, indicating strong safety data.
The announcement of PRF-110's safety data, showing maximum blood levels at only 10% of the FDA safety threshold, is a positive development. This could lead to increased investor confidence and a potential rise in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100